Skip to main content
. Author manuscript; available in PMC: 2008 Sep 1.
Published in final edited form as: Int J Mol Med. 2007 Dec;20(6):783–792.

Figure 4.

Figure 4

Intraepidermal nerve fiber profiles in the control and diabetic mice with and without the peroxynitrite decomposition catalyst FeTMPS treatment. (A) Representative image of intraepidermal nerve fiber profiles, magnification ×200; and (B) skin fiber density. Mean ± SEM, n=8–14 per group. C, control mice; D, diabetic mice. FeTMPS,1 and FeTMPS,2 administered at 5 and 10 mg kg−1 day−1, respectively. **p<0.01 vs the control mice; ##p<0.01 vs untreated diabetic mice.